Literature DB >> 21107876

Role of glial cells in neurotoxin-induced animal models of Parkinson's disease.

Hironori Yokoyama1, Hiroto Uchida, Hayato Kuroiwa, Jiro Kasahara, Tsutomu Araki.   

Abstract

Dopaminergic neurons are selectively vulnerable to oxidative stress and inflammatory attack. The neuronal cell loss in the substantia nigra is associated with a glial response composed markedly of activated microglia and, to a lesser extent, of reactive astrocytes although these glial responses may be the source of neurotrophic factors and can protect against oxidative stress such as reactive oxygen species and reactive nitrogen species. However, the glial response can also mediate a variety of deleterious events related to the production of pro-inflammatory, pro-oxidant reactive species, prostaglandins, cytokines, and so on. In this review, we discuss the possible protective and deleterious effects of glial cells in the neurodegenerative diseases and examine how these factors may contribute to the pathogenesis of Parkinson's disease. This review suggests that further investigation concerning glial reaction in Parkinson's disease may lead to disease-modifying therapeutic approaches and may contribute to the pathogenesis of this disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21107876     DOI: 10.1007/s10072-010-0424-0

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  83 in total

1.  The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease.

Authors:  B Mirza; H Hadberg; P Thomsen; T Moos
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

2.  Neuroprotection for Parkinson's disease: prospects and promises.

Authors:  C Warren Olanow; Anthony H V Schapira; Yves Agid
Journal:  Ann Neurol       Date:  2003       Impact factor: 10.422

3.  Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia.

Authors:  W G Kim; R P Mohney; B Wilson; G H Jeohn; B Liu; J S Hong
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

4.  The parkinsonian toxin MPTP: action and mechanism.

Authors:  Serge Przedborski; Vernice Jackson-Lewis; Ruth Djaldetti; Gabriel Liberatore; Miquel Vila; Slobodanka Vukosavic; Gabrielle Almer
Journal:  Restor Neurol Neurosci       Date:  2000       Impact factor: 2.406

5.  Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons.

Authors:  M M Tompkins; E J Basgall; E Zamrini; W D Hill
Journal:  Am J Pathol       Date:  1997-01       Impact factor: 4.307

6.  Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease.

Authors:  J H Kordower; S Palfi; E Y Chen; S Y Ma; T Sendera; E J Cochran; E J Cochran; E J Mufson; R Penn; C G Goetz; C D Comella
Journal:  Ann Neurol       Date:  1999-09       Impact factor: 10.422

7.  Role of reactive nitrogen and reactive oxygen species against MPTP neurotoxicity in mice.

Authors:  Hironori Yokoyama; Sho Takagi; Yu Watanabe; Hiroyuki Kato; Tsutomu Araki
Journal:  J Neural Transm (Vienna)       Date:  2008-01-31       Impact factor: 3.575

8.  Glutathione peroxidase, glial cells and Parkinson's disease.

Authors:  P Damier; E C Hirsch; P Zhang; Y Agid; F Javoy-Agid
Journal:  Neuroscience       Date:  1993-01       Impact factor: 3.590

Review 9.  Effects of steroid hormones on gene expression of glial markers in the central and peripheral nervous system: variations induced by aging.

Authors:  R C Melcangi; V Magnaghi; I Cavarretta; M A Riva; F Piva; L Martini
Journal:  Exp Gerontol       Date:  1998 Nov-Dec       Impact factor: 4.032

10.  Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice.

Authors:  Eriko Aoki; Ryohei Yano; Hironori Yokoyama; Hiroyuki Kato; Tsutomu Araki
Journal:  Exp Mol Pathol       Date:  2008-11-05       Impact factor: 3.362

View more
  23 in total

1.  The expression and release of Hsp60 in 6-OHDA induced in vivo and in vitro models of Parkinson's disease.

Authors:  Mei jiang Feng; Ling Zhang; Zhengxia Liu; Ping Zhou; Xiang Lu
Journal:  Neurochem Res       Date:  2013-08-14       Impact factor: 3.996

Review 2.  Environmental neurotoxicant-induced dopaminergic neurodegeneration: a potential link to impaired neuroinflammatory mechanisms.

Authors:  Arthi Kanthasamy; Huajun Jin; Adhithiya Charli; Anantharam Vellareddy; Anumantha Kanthasamy
Journal:  Pharmacol Ther       Date:  2019-01-22       Impact factor: 12.310

Review 3.  LXR agonists: new potential therapeutic drug for neurodegenerative diseases.

Authors:  Pei Xu; Dabing Li; Xiaotong Tang; Xiaohang Bao; Jing Huang; Yongping Tang; Yang Yang; Haiwei Xu; Xiaotang Fan
Journal:  Mol Neurobiol       Date:  2013-04-27       Impact factor: 5.590

4.  Serum prolidase activity and oxidative status in patients with diabetic neuropathy.

Authors:  Ertugrul Uzar; Yusuf Tamam; Osman Evliyaoglu; Alpaslan Tuzcu; Coskun Beyaz; Abdullah Acar; Birsen Aydın; Nebahat Tasdemir
Journal:  Neurol Sci       Date:  2011-11-27       Impact factor: 3.307

5.  Exercise improves motor deficits and alters striatal GFAP expression in a 6-OHDA-induced rat model of Parkinson's disease.

Authors:  Márcio Ferreira Dutra; Mariane Jaeger; Jocemar Ilha; Pedro Ivo Kalil-Gaspar; Simone Marcuzzo; Matilde Achaval
Journal:  Neurol Sci       Date:  2012-01-10       Impact factor: 3.307

6.  Knocking out DJ-1 attenuates astrocytes neuroprotection against 6-hydroxydopamine toxicity.

Authors:  Nirit Lev; Yael Barhum; Tali Ben-Zur; Eldad Melamed; Israel Steiner; Daniel Offen
Journal:  J Mol Neurosci       Date:  2013-03-28       Impact factor: 3.444

7.  Network and Pathway-Based Analyses of Genes Associated with Parkinson's Disease.

Authors:  Yanshi Hu; Zhenhua Pan; Ying Hu; Lei Zhang; Ju Wang
Journal:  Mol Neurobiol       Date:  2016-06-27       Impact factor: 5.590

8.  Manganese efflux in Parkinsonism: insights from newly characterized SLC30A10 mutations.

Authors:  Margaret R DeWitt; Pan Chen; Michael Aschner
Journal:  Biochem Biophys Res Commun       Date:  2013-01-26       Impact factor: 3.575

9.  Inflammatory regulation of ATP binding cassette efflux transporter expression and function in microglia.

Authors:  Christopher J Gibson; Muhammad M Hossain; Jason R Richardson; Lauren M Aleksunes
Journal:  J Pharmacol Exp Ther       Date:  2012-08-31       Impact factor: 4.030

10.  Dopaminergic neuron-specific deletion of p53 gene is neuroprotective in an experimental Parkinson's disease model.

Authors:  Xin Qi; Brandon Davis; Yung-Hsiao Chiang; Emily Filichia; Austin Barnett; Nigel H Greig; Barry Hoffer; Yu Luo
Journal:  J Neurochem       Date:  2016-07-15       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.